Drug therapies for uterine fibroids: A new approach to an old problem

Research output: Contribution to journalReview article

Abstract

Uterine fibroids are a significant problem in women's health and account for almost 40% of hysterectomies performed annually in the U.S. Until recently, medical treatments focused on drugs that block estrogen production and action. These have had limited success. Now, several novel compounds including selective progesterone receptor modulators and anti-fibrotic drugs such as pirfenidone, halofuginone, and interferons (INFs) are being investigated and show promise for the treatment of these tumors.

Original languageEnglish (US)
Pages (from-to)237-242
Number of pages6
JournalDrug Discovery Today: Therapeutic Strategies
Volume1
Issue number2
DOIs
StatePublished - Oct 2004

Fingerprint

Leiomyoma
Drug Therapy
Women's Health
Progesterone Receptors
Hysterectomy
Pharmaceutical Preparations
Interferons
Estrogens
Therapeutics
Neoplasms
pirfenidone
halofuginone

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery

Cite this

Drug therapies for uterine fibroids : A new approach to an old problem. / Nowak, Romana A.

In: Drug Discovery Today: Therapeutic Strategies, Vol. 1, No. 2, 10.2004, p. 237-242.

Research output: Contribution to journalReview article

@article{baaf059298404b19b04570bf8da84b24,
title = "Drug therapies for uterine fibroids: A new approach to an old problem",
abstract = "Uterine fibroids are a significant problem in women's health and account for almost 40{\%} of hysterectomies performed annually in the U.S. Until recently, medical treatments focused on drugs that block estrogen production and action. These have had limited success. Now, several novel compounds including selective progesterone receptor modulators and anti-fibrotic drugs such as pirfenidone, halofuginone, and interferons (INFs) are being investigated and show promise for the treatment of these tumors.",
author = "Nowak, {Romana A.}",
year = "2004",
month = "10",
doi = "10.1016/j.ddstr.2004.08.021",
language = "English (US)",
volume = "1",
pages = "237--242",
journal = "Drug Discovery Today: Therapeutic Strategies",
issn = "1740-6773",
publisher = "Elsevier Limited",
number = "2",

}

TY - JOUR

T1 - Drug therapies for uterine fibroids

T2 - A new approach to an old problem

AU - Nowak, Romana A.

PY - 2004/10

Y1 - 2004/10

N2 - Uterine fibroids are a significant problem in women's health and account for almost 40% of hysterectomies performed annually in the U.S. Until recently, medical treatments focused on drugs that block estrogen production and action. These have had limited success. Now, several novel compounds including selective progesterone receptor modulators and anti-fibrotic drugs such as pirfenidone, halofuginone, and interferons (INFs) are being investigated and show promise for the treatment of these tumors.

AB - Uterine fibroids are a significant problem in women's health and account for almost 40% of hysterectomies performed annually in the U.S. Until recently, medical treatments focused on drugs that block estrogen production and action. These have had limited success. Now, several novel compounds including selective progesterone receptor modulators and anti-fibrotic drugs such as pirfenidone, halofuginone, and interferons (INFs) are being investigated and show promise for the treatment of these tumors.

UR - http://www.scopus.com/inward/record.url?scp=13344283334&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13344283334&partnerID=8YFLogxK

U2 - 10.1016/j.ddstr.2004.08.021

DO - 10.1016/j.ddstr.2004.08.021

M3 - Review article

AN - SCOPUS:13344283334

VL - 1

SP - 237

EP - 242

JO - Drug Discovery Today: Therapeutic Strategies

JF - Drug Discovery Today: Therapeutic Strategies

SN - 1740-6773

IS - 2

ER -